5Lipsky BA, Itani K, Norden C. Treating foot infections in dia.betic patients: a randomized, multicenter, open - label trial of linezolid versus ampicillin - sulbactam/co - amoxiclav. Clinical Infectious Diseases 2004;38 : 17 - 24.
6Lavery LA, Baranoski S, Ayello EA. Options for off - loadingthe diabetic foot. Advances in Skin & Wound Care 2004 : 17(4) : 181- 186.
7Armstrong DG, Nguyen HC, Lavery LA, van Schie CH, Boulton AJ, Harkless LB. Off- loading the diabetic foot wound: a randomized clinical trial. Diabetes Care 2001;24:1019 - 1022. Erratum in:Diabetes Care 2001 ;24:1509.
8Veves A, Falanga V, Armstrong DG, Sabolinski ML. Graftskin, a human skin equivalent, is effective in the management of noninfected neuropathic diabetic foot ulcers: a prospective randomized multicenter clinical trial. Diabetes Care 2001;24:290 -295.
9Nagai MK, Embil JM. Becaplermin: recombinant platelet derived growth factor, a new treatment for healing diabetic foot ulcers.Expert Opin Biol Ther 2002;2:211 - 218.
10Kastenbauer T, Hornlein B, Sokol G, Irsigler K. Evaluation of granulocyte- colony stimulating factor (Filgrastim) in infected diabetic foot ulcers. Diabetologia 2003 ;46:27 - 30.
